CVS to hire 15,000 workers ahead of flu season, Covid-19 vaccines
[BENGALURU] US pharmacy chain CVS Health Corp on Monday said it will hire 15,000 employees in the fourth quarter of this year as the onset of winter could fuel a resurgence in the spread of Covid-19 and flu cases.
More than 10,000 of the additional employees will be full- and part-time licensed pharmacy technicians at its pharmacy locations and could help administer Covid-19 vaccines and tests.
News of additional hiring was first reported by CNBC.
The current hirings are incremental to the company's recruiting efforts announced in March.
In March, the drugstore chain said it was hiring 50,000 employees across the United States to assist patients and customers battling the coronavirus outbreak.
Last week, the US government signed agreements with CVS and Walgreens Boot Alliance to administer Covid-19 vaccines to residents of all long-term care facilities such as nursing homes, assisted-living facilities, residential care homes and adult family homes.
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
US public health officers have been drafting plans on how to distribute a coronavirus vaccine if and when it is authorised. The US Centers for Disease Control and Prevention (CDC) had set an Oct 16 deadline for states to submit plans for distributing vaccines.
REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Jim Beam owner bets on canned vodka cocktails to double revenue
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Cordlife served letter of demand, notice of claim from customers
IndoAgri appoints former EDB chairman Philip Yeo as chairman and lead independent director
GSK profit drops 23% in Q1 on higher costs